表紙
市場調查報告書

血管閉塞設備市場

Vascular Closure Devices

出版商 Global Industry Analysts, Inc. 商品編碼 939528
出版日期 內容資訊 英文 477 Pages
商品交期: 最快1-2個工作天內
價格
血管閉塞設備市場 Vascular Closure Devices
出版日期: 2020年10月01日內容資訊: 英文 477 Pages
簡介

全球血管閉塞設備市場在預測期間內預計將以5.8%的年複合成長率推移,並成長到3億7,460萬美元。

本報告提供全球血管閉塞設備市場的相關調查,市場佔有率,提供著趨勢和成長要素,新型冠狀病毒感染疾病的影響,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

本報告刊載的企業資料:Abbott Laboratories, Inc.·Cardinal Health, Inc.·Cardiva Medical, Inc.·Essential Medical, Inc.·Inseal Medical Ltd.·Medtronic PLC·Merit Medical Systems, Inc.·Terumo Corporation·Tricol Biomedical, Inc.·Tz Medical, Inc.·Vasorum Ltd.·Vivasure Medical Ltd.

目錄

簡介,調查手法,調查範圍

摘要整理

第1章 市場概要

  • 全球競爭市場佔有率
  • 全球競爭市場佔有率方案
  • 新型冠狀病毒感染疾病的影響,全球景氣衰退

第2章 關注的企業

第3章 市場趨勢及成長要素

第4章 全球市場預測

市場分析

  • 各地區市場分析
  • 美國
    • 市場現狀·要點
    • 市場佔有率:各企業
    • 市場分析
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 市場現狀·要點
    • 競爭的市場佔有率方案
    • 市場分析
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

競爭

  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP15452

Reduction in Interventional Cardiology Treatment Means Patients Are Not Receiving Timely Care. Vascular Closure Devices Slumps by -3.9% On the Back of Declining Procedures

The global market for Vascular Closure Devices is projected to decline by over -3.9% in the year 2020 and thereafter recover and grow to reach US$1.1 billion by the year 2027, trailing a post COVID-19 CAGR of 6.8% over the analysis period 2020 through 2027. A vascular closure device is a medical device designed to provide rapid hemostasis and reduce vascular complications after percutaneous femoral access and. Vascular closure devices also improve patient comfort, reduce discomfort associated with prolonged bed rest, facilitate early patient mobilization, and decrease hospital length of stay. These devices have emerged as an effective alternative to traditional mechanical compression for femoral artery closure. Suture-based and metal clip-based vascular closure devices reduce time to hemostasis when compared with manual or mechanical compression. Vascular closure devices are being widely used in patients undergoing cardiac catheterization through femoral arterial access. Cardiovascular procedures that require catheterization include interventional procedures such as angioplasty, coronary thrombectomy and placement of a stent, and diagnostic procedures that help diagnose diseased blood vessels. Vascular closure devices are particularly useful for large patients not suitable for manual compression, patients on blood thinning medications such as heparin or warfarin, and sicker or geriatric patients unable to lie flat after angiographic procedure for several hours.

The market in the current year 2020 is hurting from the disruptions and excessive pressure exerted on healthcare systems by the COVID-19 pandemic. Six months into the pandemic, this unprecedented public healthcare crisis continues to evolve and shows no signs of receding. The pandemic has impacted all areas of healthcare provision, including cardiovascular (CVD) care and has necessitated the prioritization of healthcare infrastructure for COVID-19 patients, affecting other patients across the world. With all elective surgeries cancelled and postponed there has been a significant drop in angiogram diagnostic test procedures and other cardiac surgeries. Several factors have affected delivery of timely CVD care including social distancing norms; reallocation of staff in cardiology department to covid-19 care; cancelation of cardiac imaging; cancelation of elective procedures; closure of outpatient clinics; shortage of P.P.E; hospital initiated postponement of scheduled angiograms; increased fear & anxiety among patients over safety in hospital settings; delayed diagnosis of acute coronary syndrome; deterioration of cardiac health of patients; late admission of patients to hospitals with acute precipitated cardiac emergencies; overwhelmed healthcare staff & facilities. All of these factors are reducing patient throughput in cardiology centers worldwide thereby reducing demand for cardiac care equipment including vascular closure devices.

In the post COVID-19 period as the world learns to live with the virus and healthcare services resume, the market will witness a return to growth. The postponements in screenings and delays in diagnosis and treatments will create pent-up demand for cardiac care services. The year 2021 is expected to witness steady growth in CVD surgeries requiring femoral artery cardiac catheterization. Increasing burden of CVD will continue to spur growth in the market over the medium to long-term period. CVD is one of the major causes of deaths worldwide. By 2030, the number of deaths due to CVDs is forecast to reach 24 million. The significant rise in the number of cardiac interventional procedures therefore is anticipated to create strong demand growth scenario for VCDs over the coming years. Increasing use of imaging technologies for monitoring cardiac functions and radiotherapy will also create market growth opportunities as they lead to increase heart surgeries performed. With the rise in the number of interventional procedures needing larger devices, there will be increased demand for larger-bore vascular access arteriotomies. Devices utilized for endovascular aneurysm repair (EVAR), transcatheter aortic valve implantation (TAVI), balloon aortic valvuloplasty (BAV), and percutaneous ventricular assist device (VAD) implantation require larger access, making it hard to close using traditional methods. Large-bore femoral access sites have been linked with morbidity, including higher times to obtain hemostasis, longer procedure time, delayed ambulation, higher costs and complication rates. Faster hemostasis reduces bleeding complications, saves nursing time after the procedure, increases patient throughput, quickens patient ambulation, and increases overall patient satisfaction. Further, it supports hospitals following percutaneous coronary intervention (PCI) programs. In November 2018, Vivasure Medical Ltd. launched the large-bore PerQseal closure device in European region. During the same year, Cardiva Medical Inc. received premarhet approval (PMA) for Vascade MVP venous vascular closure system from the US FDA. Vascade MVP is labelled and designed to assist in multi-site venous closures for French sized 6-12 inner diameter sheaths.

Competitors identified in this market include, among others,

  • Abbott Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cardiva Medical, Inc.
  • Essential Medical, Inc.
  • Inseal Medical Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Terumo Corporation
  • Tricol Biomedical, Inc.
  • Tz Medical, Inc.
  • Vasorum Ltd.
  • Vivasure Medical Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Vascular Closure Devices - A Prelude
    • Benefits
    • Active Approximators
    • Passive Approximators
    • External Hemostatic Devices
    • Vascular Closure Devices to Witness Steady Growth Post COVID-19
    • Interventional Cardiology to Dominate the Market
    • Passive Approximators Lead the Market
    • Femoral Access Type Leads the Market
    • United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth
    • Competition
    • Growth Restraints
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
    • Recent Market Activity
  • 3. MARKET TRENDS & DRIVERS
    • Medical Device Companies Focus on Developing Advanced Biomechanical VCDs
    • Increasing Demand for Large-bore Vascular Closure Devices
    • Select Large Bore Closure Devices
    • Cardiovascular Diseases: A Significant Contributor to Market Growth
    • EXHIBIT 1: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 2: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Aging Population Drives Demand for Vascular Closure Devices
    • EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • EXHIBIT 4: Life Expectancy for Select Countries in Number of Years: 2019
    • Increasing Healthcare Expenditure to Foster Growth
    • EXHIBIT 5: World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
    • Recent Approvals and Launches
    • Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device
    • Vascade MVP Vascular Closure System Obtains Approval from FDA
    • Large Bore PerQseal Closure Device Introduced in Europe
    • Cordis Introduces Mynx Control Vascular Closure Device
    • FDA Approves Teleflex's Vascular Closure Device
    • Vasorum Set to Commercialize a New Vascular Closure Device across the US
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Passive Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Active Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for External Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Interventional Radiology/Vascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Femoral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Radial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 26: USA Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: USA 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: USA 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: USA Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: USA 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: Canada Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: Canada 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: Canada Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: Canada 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Canada Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: Canada 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • JAPAN
    • Graying Population Spurs Growth of Vascular Closure Devices
    • EXHIBIT 6: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
    • Market Analytics
    • TABLE 43: Japan Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: Japan Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: Japan 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Japan Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Japan 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Japan Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Japan 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 52: China Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: China Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: China 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 55: China Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: China Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: China 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: China 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • EUROPE
    • Ageing Demography - An Opportunity Indicator
    • EXHIBIT 7: European Population by Age Group (2016, 2030 & 2050): Percentage Share Breakdown by Age Group for 0-14, 15-64, and 65 & Above
    • Market Analytics
    • TABLE 61: Europe Current & Future Analysis for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 62: Europe Historic Review for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: Europe 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 64: Europe Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 65: Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 73: France Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: France Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: France 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 76: France Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: France Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: France 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: France Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: France 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 82: Germany Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: Germany Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: Germany 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 85: Germany Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Germany Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Germany 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Germany Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Germany 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 91: Italy Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: Italy Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: Italy 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 94: Italy Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Italy Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: Italy 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Italy Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Italy 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 100: UK Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: UK Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: UK 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 103: UK Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: UK Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: UK 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: UK Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: UK 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 109: Spain Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: Spain Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: Spain 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 112: Spain Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Spain Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Spain 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Spain Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Spain 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 118: Russia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Russia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: Russia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 121: Russia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Russia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: Russia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Russia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Russia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 127: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Rest of Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Rest of Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Rest of Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Rest of Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Aging Populace - Potential Opportunities
    • EXHIBIT 8: Over 65 Years Individuals as % of the Total Population in Select Asian Countries
    • Healthcare Spending on the Rise
    • Market Analytics
    • TABLE 136: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 137: Asia-Pacific Historic Review for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 139: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 144: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 147: Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 148: Australia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Australia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 150: Australia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 151: Australia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Australia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 153: Australia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 155: Australia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 156: Australia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 157: India Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: India Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 159: India 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 160: India Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: India Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 162: India 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: India Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 165: India 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 166: South Korea Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 167: South Korea Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 168: South Korea 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 169: South Korea Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 170: South Korea Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 171: South Korea 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 173: South Korea Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 174: South Korea 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 175: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 176: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 177: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 179: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 182: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 184: Latin America Current & Future Analysis for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 185: Latin America Historic Review for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 186: Latin America 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 187: Latin America Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 188: Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 189: Latin America 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 191: Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 192: Latin America 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 194: Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 195: Latin America 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 196: Argentina Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 197: Argentina Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 198: Argentina 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 199: Argentina Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 200: Argentina Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 201: Argentina 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 203: Argentina Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 204: Argentina 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 205: Brazil Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 206: Brazil Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 207: Brazil 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 208: Brazil Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 209: Brazil Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 210: Brazil 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 212: Brazil Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 213: Brazil 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 214: Mexico Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 215: Mexico Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 216: Mexico 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 217: Mexico Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 218: Mexico Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 219: Mexico 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 221: Mexico Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 222: Mexico 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 223: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 224: Rest of Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 225: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 226: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 227: Rest of Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 228: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 230: Rest of Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 231: Rest of Latin America 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 232: Middle East Current & Future Analysis for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 233: Middle East Historic Review for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 234: Middle East 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 235: Middle East Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 236: Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 237: Middle East 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 239: Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 240: Middle East 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 242: Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 243: Middle East 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 244: Iran Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 245: Iran Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 246: Iran 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 247: Iran Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 248: Iran Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 249: Iran 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 251: Iran Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 252: Iran 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 253: Israel Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 254: Israel Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 255: Israel 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 256: Israel Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 257: Israel Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 258: Israel 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 260: Israel Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 261: Israel 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 262: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 263: Saudi Arabia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 264: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 265: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 266: Saudi Arabia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 267: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 269: Saudi Arabia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 270: Saudi Arabia 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 271: UAE Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 272: UAE Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 273: UAE 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 274: UAE Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 275: UAE Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 276: UAE 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 278: UAE Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 279: UAE 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 280: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 281: Rest of Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 282: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 283: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 284: Rest of Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 285: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 287: Rest of Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 288: Rest of Middle East 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 289: Africa Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 290: Africa Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 291: Africa 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
    • TABLE 292: Africa Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 293: Africa Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 294: Africa 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 296: Africa Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 297: Africa 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 36